DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Aramchol is an investigational drug.
There have been 11 clinical trials for Aramchol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2019.
The most common disease conditions in clinical trials are Fatty Liver, Non-alcoholic Fatty Liver Disease, and Liver Diseases. The leading clinical trial sponsors are Galmed Pharmaceuticals Ltd, Tel-Aviv Sourasky Medical Center, and Diamond Pharma Services.
There are forty-three US patents protecting this investigational drug and five hundred and fifteen international patents.
Recent Clinical Trials for Aramchol
|Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment||Galmed Research and Development, Ltd.||Phase 1|
|A Phase 3/4 Clinical Study to Evaluate the Efficacy and Safety of Aramchol Versus Placebo in Subjects With NASH (ARMOR)||Galmed Research and Development, Ltd.||Phase 3|
|Comparison of Aramchol Concentrations With Once or Twice Daily Dosing||Analyst Research Laboratories||Phase 1|
Top disease conditions for Aramchol
Top clinical trial sponsors for Aramchol
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Aramchol||Get Started Free||Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists||Bristol-Myers Squibb Company (Princeton, NJ) Syngene International Limited (Bangalore, Karnataka, IN)||Get Started Free|
|Aramchol||Get Started Free||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Get Started Free|
|Aramchol||Get Started Free||Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors||Pfizer Inc. (New York, NY)||Get Started Free|
|Aramchol||Get Started Free||Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof||Gilead Apollo, LLC (Foster City, CA)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Aramchol||Argentina||AR108838||2036-06-21||Get Started Free|
|Aramchol||Australia||AU2017281439||2036-06-21||Get Started Free|
|Aramchol||Brazil||BR112018076558||2036-06-21||Get Started Free|
|Aramchol||Canada||CA3029202||2036-06-21||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|